A

ARQT

Arcutis Biotherapeutics, Inc.
HealthcareBiotechnology|NASDAQ Global Select|US

Price

$23.63

Market Cap

$2.93B

Beta

1.77

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+91.34%
EPS Growth (YoY)+87.56%
Revenue CAGR 3Y+367.27%
P/E Ratio0.0
PEG Ratio
FCF Yield-0.22%
Debt / Equity0.03
Interest Coverage-1.0x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for ARQT.

ARQT — Arcutis Biotherapeutics, Inc. Stock Analysis | Tessera Alpha